Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Julphar
Boehringer Ingelheim
Chinese Patent Office
Citi
Argus Health
Harvard Business School
Covington
McKinsey

Generated: June 19, 2018

DrugPatentWatch Database Preview

Claims for Patent: 6,977,077

« Back to Dashboard

Summary for Patent: 6,977,077
Title: Method of increasing bone toughness and stiffness and reducing fractures
Abstract:The invention relates to a method for increasing the toughness and/or stiffness of bone and/or reducing the likelihood and/or severity of bone fracture by administering a parathyroid hormone. The method can be employed to increase toughness or stiffness of bone at a site of a potential or actual trauma, such as the hip or spine of a person at risk of or suffering from osteoporosis. The method of the invention can reduce the incidence of vertebral fracure, reduce the incidence of multiple vertebral fractures, reduce the severity of vertebral fracture, and/or reduce the incidence of non-vertebral fracture.
Inventor(s): Hock; Janet M. (Indianapolis, IN), Gaich; Gregory A. (Indianapolis, IN), Dere; Willard H. (Westlake Village Ventura, CA)
Assignee: Eli Lilly and Company (Indianapolis, IN)
Application Number:09/647,278
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,977,077
Patent Claims: 1. A method for the treatment of osteoporosis in a human subject, comprising administering to said subject human parathyroid hormone (1-34), without concurrent administration of an antiresorptive agent other than vitamin D or calcium, in a daily dose of 20 ug, said treatment for reducing the risk of vertebral and non-vertebral bone fracture, wherein said vitamin D is not a hydroxylated vitamin D or hydroxylated vitamin D metabolite.

2. The method according to claim 1 wherein said human subject is a man or post-menopausal woman.

3. The method according to claim 1 wherein said osteoporosis is steroid-induced.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Cantor Fitzgerald
Merck
Dow
Chubb
Accenture
US Army
Cerilliant
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.